Ametek price target raised to $215 from $205 at KeyBanc

KeyBanc analyst Steve Barger raised the firm’s price target on Ametek (AME) to $215 from $205 and keeps an Overweight rating on the shares. The firm thinks Ametek has 200-400 basis points of margin expansion in its EMG segment, as the recent Paragon Medical acquisition continues to get integrated and segment margins return to mid-20s%. KeyBanc thinks 5% organic growth +3% of M&A with average incremental margins could lead to about $8.64 in EPS by FY27, implying a high single digit compound annual growth rate from FY24-FY27.